D-0510-2025 Class II Ongoing

Recalled by Granules Pharmaceuticals Inc. — Chantilly, VA

Recall Details

Product Type
Drugs
Report Date
July 9, 2025
Initiation Date
June 24, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27,648 100-count Bottles; 5,376 500-count Bottles

Product Description

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,

Reason for Recall

Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.

Distribution Pattern

Nationwide in the USA.

Code Information

Lot # a)1400008A, Exp Date: 12/31/2025; b) 1400008B, Exp Date: 12/31/2025